Nature Reviews Clinical Oncology Journal Citation Rate 2026

ISSN 1759-4774 eISSN 1759-4782 Springer Nature GB

Q1 Quartile Top Tier

About Nature Reviews Clinical Oncology
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Nature Reviews Clinical Oncology (NRCO) is a peer-reviewed academic journal, published by Springer Nature in GB, catalogued under ISSN 1759-4774 (e-ISSN 1759-4782). As of 2026, it has a 2024 2-Year Citation Rate (OpenAlex) of 64.80 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.

Nature Reviews Clinical Oncology Citation Rate 2026 — In Context

Nature Reviews Clinical Oncology has a 2024 2-Year Citation Rate (OpenAlex) of 64.80, placing it in the Q1 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Nature Reviews Clinical Oncology operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Nature Reviews Clinical Oncology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Nature Reviews Clinical Oncology against similar journals in the field, use our journal comparison tool.

ISSN (Print) 1759-4774
ISSN (Online) 1759-4782
Publisher Springer Nature
Country United Kingdom
APC / Cost Inquire with Publisher
h-index 287
Total Works 3,368
Total Citations 307,914
2-yr Mean Citedness 28.15 (OpenAlex)
In-depth profile & metrics

Nature Reviews Clinical Oncology is published by Springer Nature and based in United Kingdom.

Editorially, Nature Reviews Clinical Oncology concentrates on Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations and Cancer Immunotherapy and Biomarkers.

Nature Reviews Clinical Oncology is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

OpenAlex records 3,368 works that have together drawn 307,914 citations, giving the journal an h-index of 287; its citation rate has held broadly steady over the last 1 years, from 61.560 (2023) to 64.800 (2024); OpenAlex puts its two-year mean citedness at 28.15.

Links
Frequently Asked Questions about Nature Reviews Clinical Oncology

Nature Reviews Clinical Oncology does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 64.800 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Nature Reviews Clinical Oncology is not an open access journal.

Nature Reviews Clinical Oncology is published by Springer Nature.

Nature Reviews Clinical Oncology is not currently listed in the major indexes we track (Scopus, DOAJ, Web of Science). This is not evidence of predatory practice — many legitimate new or regional journals are not yet indexed — but you should verify its peer-review process, editorial board, and indexing directly with the publisher before submitting.

The ISSN of Nature Reviews Clinical Oncology is 1759-4774. Its electronic ISSN (eISSN) is 1759-4782.

Nature Reviews Clinical Oncology sits in the Q1 quartile based on its latest impact factor of 64.80, ranked across all journals in our database.
Live Indexing Status
Updated March 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Unverified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
64.800
2-Year Citation Rate (OpenAlex) · 2024
Historical Trend

The impact factor has remained stable over the last 1 years (from 61.560 to 64.800), reflecting consistent citation performance.

Citation Rate by Year
Year Value Source
2024 64.800 2-Year Mean Citedness (OpenAlex)
2023 61.560 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.


Works Published per Year (2014–2025)

Annual publication volume sourced from OpenAlex. Current year omitted (partial data).

Publication & citation history by year
YearWorks publishedCitations received
2025 131 2,169
2024 128 7,551
2023 133 15,273
2022 124 15,380
2021 130 27,977
2020 146 27,374
2019 156 21,822
2018 210 29,727
2017 210 37,489
2016 219 20,560
2015 238 17,135
2014 244 15,447
Journal at a Glance
3,368
Total Works
307,914
Total Citations
287
h-index
28.15
2-Yr Mean Citedness

Source: OpenAlex — refreshed daily.

Top Research Topics

The areas where Nature Reviews Clinical Oncology most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.

Cancer Genomics and Diagnostics
Biochemistry, Genetics and Molecular Biology
427 works
252 works
Metadata

Last updated: Mar 15, 2026

Updated by: system

Get weekly updates

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google